Merck drug less effective against moderate COVID -India regulatory source
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZBQZHJ7YZBNOFETMA2FECRN3VU.jpg)
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) - Merck & Co's (MRK.N) experimental an...